DDS heads into its August 28 earnings event in a striking position: the stock has rallied 13% in a month, yet the short base has barely moved, and analysts remain firmly negative.
Short interest has drifted lower but stays structurally elevated. It has declined nearly 10% over the past month to around 953,000 shares, now representing 8.2% of the free float — still a meaningful short position, and one that has persisted through two consecutive earnings events. The ORTEX short score has eased from its mid-August peak of 74.5 to 71.1, but that still places DDS deep in the bottom decile of the universe by short-side pressure. The borrow market has loosened considerably since the previous article: availability has expanded to 165% of outstanding short interest, up from 144% a week ago, and cost to borrow has dropped to 0.53% — down 19% on the week and 35% over the past month. Bears are comfortable and under no squeeze pressure whatsoever. The consistency with the previous preview is notable: the same elevated conviction, still not a desperate scramble, just cheaper and easier now.
The analyst community is unmoved by the stock's recovery. Both JP Morgan and UBS raised price targets on August 17 — JP Morgan to $519, UBS to $468 — but both maintained negative ratings, Underweight and Sell respectively. The consensus mean target of $546 now sits roughly 15% below the current price of $642.63, a rare setup where the stock has run clean through the analyst community's best-case view. Bulls point to resilient comparable sales and effective inventory management as evidence that Dillard's merchandising model still works. Bears counter that gross margin compression — 110 basis points to 37.5% in the most recent reported quarter, missing consensus — is the more durable signal, particularly with forward earnings estimates pointing sharply lower. The EPS forward-year momentum rank sits at just the 4th percentile.
The ownership structure adds a layer of context that rarely changes but always matters here. The Dillard family collectively controls roughly 65% of shares outstanding across multiple reported holders, with Newport Trust — the employee stock ownership vehicle — holding another 29%. The effective free float is exceptionally thin. That tightness helps explain how short interest at less than a million shares can register as 8% of float, and it amplifies the stock's sensitivity to any directional move around the print. The two most recent earnings events produced a 1.8% and 1.1% one-day gain in May, then the brutal 11.8% drop on August 13. The stock has clawed back all of that decline and more — closing Monday at $642.63, up 10.9% on the week.
The August 28 print will test whether the margin deterioration that drove last month's selloff has stabilised, or whether the rally of the past two weeks has simply run ahead of a fundamental picture that analysts and short sellers still find unconvincing.
See the live data behind this article on ORTEX.
Open DDS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
